Author Archives: Hank

Pharmaceutical company recalls high blood pressure drugs over dangerous labelling mix-up A pharmaceutical company has launched a voluntary recall of a drug which may have been mislabelled — with possible “life-threatening” consequences for patients with high blood pressure, says Health … Continue reading →

NHS trusts fight health secretary over ‘value-added’ drug pricing Plans by the health secretary, Andrew Lansley, to change the way the NHS agrees drug prices with pharmaceutical companies could leave the health service footing a large bill with no real … Continue reading →

Canada Drugs Online and Online Pharmacy Coupons Team-up for Best Drug Prices The most influential decision-making factor in purchasing is the cost. Businesses apply various strategies to lower down their material, machine, manpower and methodology costs. In lieu, Six Sigma … Continue reading →

Govt will protect interests of drug industry: Scindia NEW DELHI: Amid concerns expressed by the Indian industry, the government today said in Parliament that it will protect the interest of the domestic drug industry while finalising the free trade pact … Continue reading →

Pharma pricing must reflect wider values, progressive innovation: ABPI Value-based pricing (VBP) for medicines must reflect the burden of the disease being treated, the wider societal benefits which treatments bring and the fact that innovation is often gradual, the Association … Continue reading →

No proof of drug industry sway on WHO in pandemic: report Independent experts who examined the World Health Organisation’s handling of the H1N1 pandemic said on Thursday they had found no evidence of drug industry influence on the U.N. agency’s … Continue reading →

No proof of drug industry sway on WHO in pandemic: report (Reuters) – Independent experts who examined the World Health Organisation’s handling of the H1N1 pandemic said on Thursday they had found no evidence of drug industry influence on the … Continue reading →

Drug heist could yield $43m CAREFUL planning by three thieves carrying sledgehammers has enabled them to make off with pharmaceutical drugs that carry a potential street value of $43 million. The drugs, 50 kilograms of pseudoephedrine and 67 kilograms of … Continue reading →

Ironwood Pharmaceuticals Provides Fourth Quarter 2010 Investor Update Linaclotide In November, Ironwood and its U.S. partner, Forest Laboratories, Inc., completed the clinical efficacy portion of the linaclotide development program to support upcoming regulatory submissions in both the U.S. and the … Continue reading →

Fixed ARV pricing may hamper Aspen’s growth Aspen Pharmacare, Africa’s largest pharmaceutical manufacturer has announced a 33% increase in revenue for the six months to December 32 last year but warns that performance may decline due to single exit prices … Continue reading →